Lindus Health
Trials 3x faster. Patients enroll sooner.
London, England, UK
Lindus Health is a company focused on accelerating clinical trials.
Problem Statement
Traditional clinical trials are inefficient, costly, and slow, delaying the process of bringing new treatments to market.
Core Technology
AI
Key Differentiators
AI-driven clinical research services; Fixed-fee, milestone-based pricing model; Acts as an 'anti-CRO' to bring treatments to market faster
Clinical Focus
Asthma; Diabetes; Hypertension; Weight Management; Social Anxiety; Acne; Major Depressive Disorder; Chronic Fatigue Syndrome; Insomnia
Company Info
- Business Model
- Hybrid
- Total Funding
- 18,000,000
- Website
- www.lindushealth.com/
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
Published in Nature for proprietary AI predicting trial outcomes. ARIA-funded partnership with University of Oxford for safe, reliable AI in trial design. CDISC collaboration to standardize clinical trial data for FDA submission. Active portfolio: Phase 3 trials (MDD device therapy), Phase 2+ studies across diabetes, asthma, psychiatry.
MedStartr Index Score
?What do you think of Lindus Health?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.